20 May 2013
Keywords: Eli Lilly, Elanco, Johnson & Johnson, Janssen, Animal health, M&A
Article | 15 March 2011
US drug major Eli Lilly’s (NYSE: LLY) animal health division Elanco has made an irrevocable, unconditional offer to ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.